As a potential treatment of COVID-19: Montelukast

Thumbnail
Göster/Aç
Tarih
2020
Yazar
Fidan, Cihan
Aydogdu, Ayse
Üst veri
Tüm öğe kaydını göster
Özet
It has been hypothesized that Montelukast, a cysteinyl leukotriene (cysLT) receptor antagonist, with effects of anti-inflammatory, suppress oxidative stress and reduce affect cytokine production, may limited progression of the disease on COVID-19 infection.
Bağlantı
http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC7211747&blobtype=pdf
http://hdl.handle.net/11727/5865
Koleksiyonlar